Open AccessHER2 and topoisomerase IIα: possible predictors of response to neoadjuvant chemotherapy for breast cancer patients
Author(s) -
Li Zhu,
Ya-fen LI,
Wei-guo CHEN,
Jianxing He,
Chenghong Peng,
Zheng-gang ZHU,
Hongwei Li
Publication year - 2008
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/00029330-200810020-00003
Subject(s) - epirubicin , medicine , breast cancer , chemotherapy , cyclophosphamide , oncology , neoadjuvant therapy , cancer , pathological , immunohistochemistry , topoisomerase , fluorouracil , clinical endpoint , clinical trial , biology , biochemistry , enzyme